Newsletter Subject

Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Sep 23, 2023 11:16 AM

Email Preheader Text

Weekly Review Saturday, September 23, 2023 THE BREAK ROOM CME SPOTLIGHT THE BREAK ROOM ADVERTISEMENT

[MEDPAGE TODAY]( Weekly Review Saturday, September 23, 2023 [Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough]( [I Just Got Over COVID. Do I Need an Updated Shot?]( [Medical Debt Is Killing Our Patients]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Navigating the Evolving Treatment Paradigm for Myelodysplastic Syndromes and Myeloproliferative Neoplasms]( [Clarifying the 'Duty to Warn' in North Carolina]( [Here Are This Year's Top Schools for an Undergraduate Nursing Degree]( THE BREAK ROOM [Play Today's Wordosis: Our Medical Word Game]( ADVERTISEMENT [Are Paxlovid and Lagevrio Equals?]( CME SPOTLIGHT [Optimizing Biomarker-Directed Therapy to Advance CRC Care: A Clinical Connections Session]( ['Con Man' Gets Another Top Hospital Job, This Time at Penn Medicine]( [PA's Murder Trial; Doc's Manslaughter Charge; Cardiologist's Kickback Settlement]( [Guide to the Coronary Artery Calcium Scan: 2023 Update]( CME SPOTLIGHT [Advancing the Integration of CAR T-Cell Therapy in Community Oncology Centers: A Transformative Quality Improvement Initiative at a Large Community-Based Network]( [When It Comes to Vaccine Strategy, Be Careful Comparing the U.S. to Other Countries]( [Keto for Kids With Diabetes Carries Risk, AAP Warns]( [Gabapentin No Help for Lingering COVID-Induced Olfactory Dysfunction]( CME SPOTLIGHT [Advancing Sustainable Practice Change to Improve TNBC Care in Community Based Settings: Insights From an AON Quality Improvement Initiative]( [Emotional CPR as an Alternative to Coercive Mental Health Treatment]( [Acrylic Window to the Brain; Chronic Fatigue Discovery; AI Spots Parkinson's Risk]( [From Physician to Politician]( CME SPOTLIGHT [Advancing Personalized Care in HR+/HER2- and Triple-Negative Breast Cancer]( [Medicare Advantage Ads Should Look Different This Year]( [Direct-to-Consumer Lab Tests Raise Ethical Questions, Researchers Say]( [FXI Inhibitor Cuts Bleeds in Afib; COAPT Extends to Real World; AI Stroke Triage]( CME SPOTLIGHT [Current Unmet Needs and Paths to Advance NF1 PN Care]( ['Dr. Google' Meets Its Match: Dr. ChatGPT]( [Schizophrenia Sexual Dysfunction; Nuplazid Box Warning Tweak; Psych Practice Fraud?]( [Loneliness Needs to Be Treated Like Any Other Health Condition, Researcher Suggests]( CME SPOTLIGHT [Navigating the Rapidly Evolving DLBCL Treatment Landscape to Deliver Quality Care]( [Despite Taboo, Med Students, Doctors Use Substances Too]( [Want Better Health Outcomes? Check Out What Other Countries Do]( [FDA Advisors Grapple With Logistical, Ethical Issues of Artificial Womb Technology]( CME SPOTLIGHT [Evidence-Based Strategies to Improve Outcomes for Patients With Gastroesophageal Cancers]( [Vaccine Research and Combating the Anti-Science Movement Go Hand in Hand]( ['You Have No Idea How Much It Pains Me': What We Heard This Week]( [The GLP-1 Agonist Plateau No One's Talking About]( [FDA Approves Another SGLT2 Inhibitor for Treating CKD]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2023-09-23&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.